[empressplay]

Some commenters are making me wonder if Theranos' new narrative is that their value proposition is opening blood collection facilities in drug stores / supermarkets.

If it is, and Theranos feels this "new" value proposition is enough to justify their valuation, I'm not sure what they're smoking, but I would sure like some!